These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11214777)

  • 1. Correlation between acetylation phenotype and genotype in Chinese women.
    Zhao B; Seow A; Lee EJ; Lee HP
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):689-92. PubMed ID: 11214777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetyltransferase 2 acetylation polymorphism: prevalence of slow acetylators does not differ between atopic dermatitis patients and healthy subjects.
    Brocvielle H; Muret P; Goydadin AC; Boone P; Broly F; Kantelip JP; Humbert P
    Skin Pharmacol Appl Skin Physiol; 2003; 16(6):386-92. PubMed ID: 14528063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on N-Acetyltransferase (NAT2) Genotype Relationships in Emiratis: Confirmation of the Existence of Phenotype Variation among Slow Acetylators.
    Al-Ahmad MM; Amir N; Dhanasekaran S; John A; Abdulrazzaq YM; Ali BR; Bastaki S
    Ann Hum Genet; 2017 Sep; 81(5):190-196. PubMed ID: 28653770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylator status and N-acetyltransferase 2 gene polymorphisms; phenotype-genotype correlation with the sulfamethazine test.
    Taja-Chayeb L; González-Fierro A; Miguez-Muñoz C; Trejo-Becerril C; Cruz-Hernandez Ede L; Cantu D; Agundez JA; Vidal-Millan S; Gutierrez O; Dueñas-González A
    Pharmacogenet Genomics; 2011 Dec; 21(12):894-901. PubMed ID: 21946899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetyltransferase (NAT2) polymorphism and breast cancer susceptibility: a lack of association in a case-control study of Turkish population.
    Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE
    Int J Toxicol; 2004; 23(1):25-31. PubMed ID: 15162844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative analysis of N-acetylation polymorphism in humans as determined by phenotyping and genotyping].
    Goldenkova-Pavlova IV; Bruskin SA; Abdeev RM; Markarova EV; Bigvava SG; Radkevich LA; Kozhekbaeva ZhM; Glotov AS; Gra OA; Zasedatelev AS; Nasedkina TV; Kurdanov KhA; Piruzian ES
    Genetika; 2006 Aug; 42(8):1143-50. PubMed ID: 17025166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylation phenotype and genotype in aboriginal leprosy patients from the north-west region of Western Australia.
    Ilett KF; Chiswell GM; Spargo RM; Platt E; Minchin RF
    Pharmacogenetics; 1993 Oct; 3(5):264-9. PubMed ID: 8287065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphic N-acetyltransferase (NAT2) genotyping of Emiratis.
    Woolhouse NM; Qureshi MM; Bastaki SM; Patel M; Abdulrazzaq Y; Bayoumi RA
    Pharmacogenetics; 1997 Feb; 7(1):73-82. PubMed ID: 9110365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical relevance of N-acetyltransferase type 2 (NAT2) genetic polymorphism].
    Furet Y; Bechtel Y; Le Guellec C; Bechtel PR; Autret-Leca E; Paintaud G
    Therapie; 2002; 57(5):427-31. PubMed ID: 12611196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arylamine N-acetyltransferase 2 slow acetylator polymorphisms in unrelated Iranian individuals.
    Bakayev VV; Mohammadi F; Bahadori M; Sheikholslami M; Javeri A; Masjedi MR; Velayati AA
    Eur J Clin Pharmacol; 2004 Sep; 60(7):467-71. PubMed ID: 15316701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of N-acetyltransferase activity: should caffeine phenotyping and NAT2 genotyping be used interchangeably in epidemiological studies?
    Le Marchand L; Sivaraman L; Franke AA; Custer LJ; Wilkens LR; Lau AF; Cooney RV
    Cancer Epidemiol Biomarkers Prev; 1996 Jun; 5(6):449-55. PubMed ID: 8781741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk.
    Selinski S; Blaszkewicz M; Ickstadt K; Hengstler JG; Golka K
    Arch Toxicol; 2013 Dec; 87(12):2129-39. PubMed ID: 24221535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Polymorphism in the N-acetyltransferase 2 gene in patients with lung cancer. Short communication].
    Zabost A; Roszkowska-Śliż B; Wiatr E; Radzikowska E; Rogala E; Zych J; Zwolska Z; Augustynowicz-Kopeć E; Roszkowski-Śliż K; Szczepulska-Wójcik E
    Pneumonol Alergol Pol; 2012; 80(4):323-8. PubMed ID: 22714076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential association for N-acetyltransferase 2 genotype and phenotype with bladder cancer risk in Chinese population.
    Quan L; Chattopadhyay K; Nelson HH; Chan KK; Xiang YB; Zhang W; Wang R; Gao YT; Yuan JM
    Oncotarget; 2016 Jun; 7(26):40012-40024. PubMed ID: 27223070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arylamine N-acetyltransferase-2 genotypes in the Thai population.
    Kukongviriyapan V; Prawan A; Tassaneyakul W; Aiemsa-Ard J; Warasiha B
    Br J Clin Pharmacol; 2003 Mar; 55(3):278-81. PubMed ID: 12630978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between N-acetyltransferase 2 (NAT2) genetic polymorphism and development of breast cancer in post-menopausal Chinese women in Taiwan, an area of great increase in breast cancer incidence.
    Huang CS; Chern HD; Shen CY; Hsu SM; Chang KJ
    Int J Cancer; 1999 Jul; 82(2):175-9. PubMed ID: 10389748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.
    Hein DW; Doll MA; Fretland AJ; Leff MA; Webb SJ; Xiao GH; Devanaboyina US; Nangju NA; Feng Y
    Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):29-42. PubMed ID: 10667461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher frequency of aberrant crypt foci in rapid than slow acetylator inbred rats administered the colon carcinogen 3,2'-dimethyl-4-aminobiphenyl.
    Feng Y; Fretland AJ; Rustan TD; Jiang W; Becker WK; Hein DW
    Toxicol Appl Pharmacol; 1997 Nov; 147(1):56-62. PubMed ID: 9356307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetyltransferase polymorphism in patients with Behçet's disease.
    Aynacioglu AS; Bozkurt A; Nacak M; Kortunay S; Tunc R; Dincel A; Kayaalp SO
    Eur J Clin Pharmacol; 2001 Nov; 57(9):659-62. PubMed ID: 11791896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.